<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04358315</url>
  </required_header>
  <id_info>
    <org_study_id>I 80518</org_study_id>
    <secondary_id>NCI-2019-06320</secondary_id>
    <secondary_id>I 80518</secondary_id>
    <secondary_id>P30CA016056</secondary_id>
    <secondary_id>U54CA228110</secondary_id>
    <nct_id>NCT04358315</nct_id>
  </id_info>
  <brief_title>Consumer Assessment of Tobacco Flavor and Odor</brief_title>
  <official_title>Consumer Assessment of Tobacco Flavor and Odor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Roswell Park Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Roswell Park Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial studies consumer assessments of tobacco flavor and odor. This study will compare
      the ability of expert and consumer panels to identify and characterize flavors, determine
      threshold detection levels for individual and mixed flavors, and identify the dominant flavor
      of mixtures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:

      I. Develop consumer (untrained) sensory panels to identify and assess characterizing flavors
      in electronic (e)-liquids.

      OUTLINE:

      Non-user panelists smell and user panelists puff flavored e-liquids and answer questions
      about the products.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 19, 2019</start_date>
  <completion_date type="Anticipated">September 19, 2022</completion_date>
  <primary_completion_date type="Anticipated">September 19, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Flavor identification and evaluation</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Subjects will be asked to identify various concentrations of flavored e-liquids</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Specific flavor detection thresholds</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Subjects will rate intensity of odors of e liquids</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Flavor combination thresholds</measure>
    <time_frame>Up to 12 months</time_frame>
    <description>Subjects will rate a combination of two e-liquids combined</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Current Vaper</condition>
  <condition>Healthy Subject</condition>
  <arm_group>
    <arm_group_label>Observational (smell or puff e-liquids)</arm_group_label>
    <description>Non-user panelists smell and user panelists puff flavored e-liquids and answer questions about the products.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Behavioral Intervention</intervention_name>
    <description>Smell or puff e-liquids</description>
    <arm_group_label>Observational (smell or puff e-liquids)</arm_group_label>
    <other_name>Behavior Conditioning Therapy</other_name>
    <other_name>behavior modification</other_name>
    <other_name>Behavior or Life Style Modifications</other_name>
    <other_name>Behavior Therapy</other_name>
    <other_name>Behavioral Interventions</other_name>
    <other_name>Behavioral Modification</other_name>
    <other_name>Behavioral Therapy</other_name>
    <other_name>Behavioral Treatment</other_name>
    <other_name>Behavioral Treatments</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Observational (smell or puff e-liquids)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Current daily vapers and nonusers in the greater Buffalo and Rochester areas
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  CONSUMER USER: Current daily vapers of products containing nicotine

          -  CONSUMER USER: No concurrent use of other tobacco products

          -  CONSUMER USER: General good health

          -  CONSUMER USER: No allergies

          -  CONSUMER USER: No self-reported taste or smell deficits

          -  CONSUMER USER: Not pregnant or lactating

          -  CONSUMER USER: No medications known to interfere with taste/smell

          -  CONSUMER USER: Passing scores on the Brief Smell Identification Test (B-SIT),
             phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests

          -  CONSUMER NONUSER: No use of tobacco or nicotine products in the last year

          -  CONSUMER NONUSER: General good health

          -  CONSUMER NONUSER: No allergies

          -  CONSUMER NONUSER: No self-reported taste or smell deficits

          -  CONSUMER NONUSER: Not pregnant or lactating

          -  CONSUMER NONUSER: No medications known to interfere with taste/smell

          -  CONSUMER NONUSER: Passing scores on the Brief Smell Identification Test (B-SIT),
             phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests

        Exclusion Criteria:

          -  CONSUMER USER: Outside age range

          -  CONSUMER USER: Not current daily vapers

          -  CONSUMER USER: Concurrent use of other tobacco products

          -  CONSUMER USER: Fair or poor general health

          -  CONSUMER USER: Allergies

          -  CONSUMER USER: Self-reported taste or smell deficits

          -  CONSUMER USER: Pregnant or lactating

          -  CONSUMER USER: Medications known to interfere with taste/smell

          -  CONSUMER USER: Failing scores on the Brief Smell Identification Test (B-SIT),
             phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests

          -  CONSUMER NONUSER: Outside age range

          -  CONSUMER NONUSER: Use of tobacco or nicotine products in the last year

          -  CONSUMER NONUSER: Fair or poor general health

          -  CONSUMER NONUSER: Allergies

          -  CONSUMER NONUSER: Self-reported taste or smell deficits

          -  CONSUMER NONUSER: Pregnant or lactating

          -  CONSUMER NONUSER: Medications known to interfere with taste/smell

          -  CONSUMER NONUSER: Failing scores on the Brief Smell Identification Test (B-SIT),
             phenylthiocarbamine (PTC) and 6-n-propylthiouracil (PROP) smell and taste tests
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Richard J O'Connor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Roswell Park Cancer Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Roswell Park Cancer Institute</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14263</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard J. O'Connor</last_name>
      <phone>716-845-4517</phone>
      <email>Richard.OConnor@roswellpark.org</email>
    </contact>
    <investigator>
      <last_name>Richard J. O'Connor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 13, 2020</study_first_submitted>
  <study_first_submitted_qc>April 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 24, 2020</study_first_posted>
  <last_update_submitted>April 20, 2020</last_update_submitted>
  <last_update_submitted_qc>April 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

